Type I IFN signature in primary Sjögren's syndrome patients (Q38180717)

30 August 2017

Type I IFN signature in primary Sjögren's syndrome patients (English)

1 reference

30 August 2017

1 reference

Zana Brkic

1

1 reference

PubMed ID

24450331

30 August 2017

Marjan A Versnel

series ordinal

2

1 reference

30 August 2017

22 January 2014

1 reference

Expert Review of Clinical Immunology

30 August 2017

1 reference

30 August 2017

10

1 reference

30 August 2017

4

1 reference

30 August 2017

457-467

1 reference

Primary Sjogren syndrome: clinical and immunopathologic features

30 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Clinical manifestations and early diagnosis of Sjögren syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Virus interference. I. The interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Activation of the type I interferon pathway in primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

The type I interferon system in the etiopathogenesis of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

The type I interferon system in the development of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Overview of the biology of type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferons at age 50: past, current and future impact on biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Abducens palsy and Sjogren's syndrome induced by pegylated interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferon-mediated fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferons as pathogenic effectors in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Peripheral blood gene expression profiling in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Type I interferon receptor deficiency prevents murine Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Role of type I interferons in the activation of autoreactive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Type I interferon modulates the battle of host immune system against viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

IL-17: a new actor in IFN-driven systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

The role of dendritic cells in the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Apoptosis in the pathogenesis of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Quantitative analysis of lacrimal gland function, apoptotic figures, Fas and Fas ligand expression of lacrimal glands in dry eye patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Development of Autoimmune Exocrinopathy Resembling Sjögren's Syndrome in Estrogen-Deficient Mice of Healthy Background

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Novel cell death program leads to neutrophil extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Apoptosis and NET formation in the pathogenesis of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Association of an IRF5 gene functional polymorphism with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-α)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.876364

10.1586/1744666X.2014.876364

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24450331